CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, a science-first software company transforming healthcare data for research and discovery, and Emory Healthcare, the most comprehensive academic health ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference today announced a strategic research and data science partnership with Parabilis Medicines, Inc. (“Parabilis”) focused on supporting the clinical ...
Nference has raised $60 million. The Mayo Clinic-backed series B round positions nference to forge ahead with its effort to capture and analyze health data, including unstructured information, to help ...
-- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most often due to lack of efficacy; inability to wake up was most common reason for missing ...
EHR data company nference on Wednesday launched its real-world evidence generation platform and expanded its existing partnership with the Mayo Clinic. The platform, dubbed nSights, collects ...
Looking to broaden its use of artificial intelligence to help lock down its R&D work, Johnson & Johnson’s biotech unit Janssen has penned a new deal with AI specialist nference. The multiyear deal, ...
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. The ...
A new study from the artificial intelligence (AI)-driven health technology company, nference, and the Mayo Clinic, finds no links among any of the three COVID-19 vaccines and cerebral venous sinus ...
CAMBRIDGE, Mass., March 23, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced publication in EClinicalMedicine of study "Pre-existing conditions are associated ...
CAMBRIDGE, Mass., April 17, 2025 /PRNewswire/ -- nference, a company dedicated to transforming healthcare by making biomedical data computable, today announced a collaboration with BeiGene, Ltd, a ...
DUBLIN, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, and nference, a health tech ...
This morning nference, maker of a software platform that helps to synthesize biomedical information, scored $60 million in Series C funding. Matrix Capital Management led the round with participation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results